(Total Views: 208)
Posted On: 01/04/2017 7:17:36 AM
Post# of 23045
$AGRX: 1.59 now after DIP...nice flipper... RBC Capital analyst, Randall Stanicky, reiterated his Outperform rating on shares of Agile Therapeutics (NASDAQ: AGRX) but cut his price target to $8 from $15
http://www.streetinsider.com/Analyst+Comments...88352.html
http://www.streetinsider.com/Analyst+Comments...88352.html
(1)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
Scroll down for more posts ▼
